Table 2.
LI | LI+BFR | HI | ||||
---|---|---|---|---|---|---|
Baseline | Exercise | Baseline | Exercise | Baseline | Exercise | |
LP trial | ||||||
sBP (mmHg) | 125 ± 2 | 143 ± 3a , b | 127 ± 2 | 152 ± 3a | 127 ± 2 | 153 ± 3a |
dBP (mmHg) | 67 ± 2 | 75 ± 1a | 68 ± 2 | 85 ± 2a , c | 65 ± 2 | 71 ± 2 |
MAP (mmHg) | 86 ± 2 | 97 ± 2a | 87 ± 1 | 107 ± 2a , c | 86 ± 2 | 98 ± 2a |
HR (beats·min−1) | 65 ± 3 | 109 ± 4a | 71 ± 4d | 116 ± 4a , c | 76 ± 4d | 138 ± 5a , c |
HR (% APHRmax) | 34 ± 2 | 55 ± 3a | 37 ± 2d | 58 ± 3a , c | 39 ± 2d | 72 ± 2a , c |
SV (mL) | 112 ± 9 | 109 ± 5 | 120 ± 8 | 102 ± 5a | 124 ± 8 | 94 ± 4a , e |
(L·min−1) | 7.2 ± 0.5 | 11.5 ± 0.4a , b | 8.3 ± 0.6 | 11.5 ± 0.3a , b | 9.1 ± 0.6 | 12.6 ± 0.5a |
TM trial | ||||||
sBP (mmHg) | 118 ± 2 | 123 ± 2 | 118 ± 4 | 124 ± 2 | 117 ± 2 | 140 ± 3a , c |
dBP (mmHg) | 68 ± 2 | 72 ± 2a | 68 ± 2 | 76 ± 2a , b | 67 ± 2 | 68 ± 2a |
MAP (mmHg) | 85 ± 2 | 89 ± 2a | 84 ± 2 | 92 ± 2a | 83 ± 1 | 91 ± 2a |
HR (beats·min−1) | 68 ± 3 | 88 ± 3a | 71 ± 3 | 92 ± 3a | 73 ± 3 | 157 ± 3a , c |
HR (% APHRmax) | 35 ± 2 | 46 ± 1a | 37 ± 2 | 48 ± 1a | 38 ± 2e | 79 ± 3a , c |
SV (mL) | 75 ± 5 | 109 ± 5a | 72 ± 6 | 96 ± 4a | 70 ± 5 | 119 ± 5a , f |
(L·min−1) | 5.1 ± 0.4 | 9.5 ± 0.3a | 5.1 ± 0.3 | 8.6 ± 0.2a | 5.0 ± 0.3 | 18.5 ± 0.8a , c |
Data are Mean ± SEM. BFR, blood‐flow restriction; LI, light‐intensity; HI, high‐intensity; LP, leg‐press trial; TM, treadmill trial.
Different to Baseline (P < 0.05).
Main effect for BOUT versus HI (P < 0.05).
Different to EXERCISE in all other BOUTS (P < 0.05).
Different to Baseline in all other BOUTS (P < 0.05).
Different to LI only (P < 0.05).
Different to LI+BFR only (P < 0.05).